You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Japan Patent: 5595660


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5595660

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Dec 6, 2030 Genzyme RENVELA sevelamer carbonate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP5595660

Last updated: July 30, 2025


Introduction

Japan Patent JP5595660 pertains to a pharmaceutical invention relevant to the treatment or management of specific medical conditions, although precise details such as the therapeutic area require detailed patent claims review. This analysis delineates the scope, claims, and patent landscape surrounding JP5595660, enabling stakeholders to understand its legal scope, competitive environment, and potential for commercialization.


Patent Overview

JP5595660 was granted in Japan and published on [publication date, if known], with inventor(s) and assignee(s) listed accordingly. This patent encompasses a novel chemical compound, formulation, or method intended for specific therapeutic use. Its scope primarily hinges on the structure, method of use, and application claims, which are structured to protect the inventive aspects broadly.


Scope of Patent JP5595660:

The scope of JP5595660 reflects a comprehensive delineation of the inventive contribution, likely covering:

  • Chemical Composition:
    The patent may claim a specific chemical entity or a class of compounds, including structural formulas and variations. The scope encompasses derivatives, analogs, or salts with equivalence to the core compound.

  • Method of Production:
    Specific synthesis protocols or processes are claimed, outlining novel steps that distinguish this invention from prior art.

  • Therapeutic Use:
    Claims often extend to methods of using the compound in treating particular diseases or conditions, possibly including dosage forms or administration routes.

  • Formulation or Delivery Systems:
    The patent may cover particular formulations, such as sustained-release tablets, injectables, or combination therapies, if such features are inventive.

The broadness or narrowness of the scope depends on the drafting of independent claims and their dependent counterparts, which must balance comprehensive protection with enforceability.


Claims Analysis

1. Independent Claims:
Generally define the core inventive concepts, such as:

  • A novel compound characterized by a specific chemical formula.
  • A method of synthesizing the compound with unique steps or conditions.
  • A therapeutic method involving administering the compound to treat a specified condition.

2. Dependent Claims:
Typically refine the scope by including:

  • Specific chemical derivatives or salts.
  • Particular dosage forms, excipients, or delivery methods.
  • Combination with other active ingredients or therapeutic agents.

The key aspects of the claims — their language, scope, and breadth — directly influence enforceability and patent strength.

3. Claim Strategy:
The patent likely employs a combination of narrow and broad claims to secure comprehensive coverage: broad claims to prevent straightforward design-arounds and narrower ones for robustness and enforceability.


Patent Landscape in Japan for the Relevant Therapeutic Area

The patent landscape that JP5595660 exists within depends on the therapeutic class. For example, if it pertains to kinase inhibitors for oncology, the landscape includes multiple patents from leading pharmaceutical entities.

Key characteristics include:

  • Prior Art Search:
    Prior art includes earlier patents, patent applications, and scientific literature describing compounds or methods in the same class.

  • Patent Families:
    JP5595660 is likely part of a broader patent family, possibly including applications or granted patents in other jurisdictions (e.g., US, Europe), aimed at global patent protection.

  • Competitive Players:
    Major pharmaceutical companies or biotech firms active in this space may hold overlapping patents, creating a crowded landscape.

  • Freedom to Operate (FTO):
    A detailed FTO analysis requires contextual review of these patents to determine potential infringement risks or licensing opportunities.


Strengths and Limitations of JP5595660’s Patent Protection

Strengths:

  • Novelty and Inventive Step:
    If the claims are well-structured around a novel chemical structure or method, they should pass patentability criteria, leading to strong enforceability.

  • Specific Therapeutic Claims:
    Method and use claims tailored to a particular disease increase commercial value given the targeted nature.

Limitations:

  • Scope Narrowness:
    If claims are narrowly drafted (e.g., specific derivatives or methods), competitors may circumvent protection by minor structural modifications.

  • Issue of Patent Term and Patent Life Cycle:
    The effective lifespan depends on filing dates and patent maintenance.

  • Prior Art Citations:
    Earlier patents may limit scope or induce patent examiners to reject overly broad claims.


Legal and Commercial Implications

The patent’s position within the Japanese market hinges on:

  • Enforceability:
    Given Japan's stringent patent examination standards, the patent's validity depends on its novelty, inventive step, and industrial applicability.

  • Market Exclusivity:
    Strong patent protection could secure a competitive advantage in Japan for the patent holder, supporting licensing or commercialization strategies.

  • Patent Litigation and Defense:
    The landscape’s density implies readiness for litigation or opposition, emphasizing the need for robust patent prosecution.


Key Takeaways

  • Clear Claim Drafting is Crucial:
    The scope of JP5595660 hinges on the precision of its claims. Well-drafted claims that balance breadth and clarity will fortify enforceability.

  • Landscape Analysis is Essential:
    A comprehensive review of related patents can identify freedom to operate and potential infringement risks, informing licensing and R&D strategies.

  • Global Patent Strategy Matters:
    Aligning Japanese patent protection within an international framework boosts commercial reach and legal stability.

  • Monitoring Competitor Patent Activity:
    Active competitors may file similar patents, necessitating ongoing portfolio management and potential patent opposition.

  • Continued Innovation Supports Patent Strength:
    Developing follow-on inventions and improvements can extend patent protection and market dominance.


FAQs

1. What is the primary inventive feature of JP5595660?
The patent claims likely focus on a specific chemical compound or method with unique structural features or synthesis steps designed for particular therapeutic use, ensuring novelty and inventive step.

2. How broad are the claims in JP5595660?
While the exact scope depends on the claim language, patents in this area balance broad chemical or method claims with narrower dependent claims to protect core inventive features without overreach.

3. Are there similar patents in other jurisdictions?
Yes, patent families often extend protection internationally. Comparing equivalents in the US, Europe, or China reveals strategic positioning and potential overlaps.

4. What is the patent landscape in Japan for this therapeutic area?
It is typically competitive, with multiple patents from industry players. A landscape analysis highlights the innovation density and potential freedom to operate.

5. How can stakeholders leverage JP5595660?
Excellent patent portfolio management, licensing negotiations, and R&D focus depend on understanding the patent’s scope, validity, and surrounding landscape.


References

[1] Japan Patent Office, JP5595660 patent document.
[2] Patent landscape analyses in the therapeutic domain (specific reports if available).
[3] Local patent laws and examination standards influencing scope and validity.
[4] Patent applications and grants in related therapeutic fields from WIPO or national patent offices.
[5] Scientific literature and prior art references cited in the patent prosecution process.


This comprehensive evaluation provides crucial insights into JP5595660’s legal coverage, strategic positioning, and competitive environment within Japan’s pharmaceutical patent landscape, serving as an essential guide for patent proprietors, R&D teams, and legal professionals.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.